


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-13.86%
+0.55%
+1.48%
+2.32%
-1.63%
IRWD
Ironwood Pharma
$3.79
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market
IRWD Price Performance
$4.79 (-20.88%)
$3.49 (+8.60%)
$1.46 (+159.59%)
$1.54 (+146.10%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
IRWD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IRWD Street Sentiment is extremely bullish and have positive views on the near-term outlook
IRWD has Fair risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 04, 2026
Upgrade
Outperform
Craig-Hallum
Jan 06, 2026
Upgrade
Market
Citizens
What is IRWD current stock price?
What are IRWD stock strengths?
What is IRWD Risk Level?
What is IRWD market cap and volume?
What is IRWD current Stock IQ?
Should I buy IRWD stock right now?
Is IRWD a Strong Buy right now?
What does a 'Strong Buy' rating mean for IRWD?
What does a 'Strong Sell' rating mean for IRWD?
What factors influence IRWD's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
IRWD
Ironwood Pharma
Current Price
$3.79

IRWD Price Performance
$4.79 (-20.88%)
$3.49 (+8.60%)
$1.46 (+159.59%)
$1.54 (+146.10%)
IRWD Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
IRWD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IRWD Street Sentiment is extremely bullish and have positive views on the near-term outlook
IRWD has Fair risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
IRWD Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market
IRWD Latest Analysis
IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock?. Ironwood surges 307% in six months on rising Linzess demand and an upbeat 2026 revenue outlook. The company is also making good pipeline progress.
Thu Feb 12, 2026
Does Ironwoods ish 2026 View Signal Greater Linzess Adoption?. IRWD expects Linzess demand to accelerate driving a ish 2026 outlook with revenue growth higher profits and expanding adoption.
Thu Feb 5, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IRWD Stock trends
IRWD Stock performance
IRWD Stock analysis
IRWD investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.